Varughese V, Nagesh V, Moliya P, Gonzalez N, Martinez E, Mujadzic H
Med Sci (Basel). 2025; 13(1).
PMID: 39982244
PMC: 11843908.
DOI: 10.3390/medsci13010019.
Faramarzpour M, Hosseiniazar M, Hooshmand Gharabagh L
Caspian J Intern Med. 2024; 16(1):47-57.
PMID: 39619748
PMC: 11607126.
DOI: 10.22088/cjim.16.1.47.
Namdar A, Ahadi M, Hoseini S, Vosoghinia H, Rajablou H, Farsi S
Avicenna J Phytomed. 2023; 13(6):615-625.
PMID: 38106627
PMC: 10719728.
DOI: 10.22038/AJP.2023.21919.
Goliopoulou A, Theofilis P, Oikonomou E, Anastasiou A, Pantelidis P, Gounaridi M
Int J Mol Sci. 2023; 24(18).
PMID: 37762592
PMC: 10532416.
DOI: 10.3390/ijms241814292.
Khoshbaten M, Maleki S, Hadad S, Baral A, Rocha A, Poudel L
Health Sci Rep. 2023; 6(9):e1554.
PMID: 37701352
PMC: 10493365.
DOI: 10.1002/hsr2.1554.
Prevalence of Non-alcoholic Fatty Liver Disease Detected by Computed Tomography in the General Population Compared with Ultrasonography.
Ito Y, Yoshioka K, Hayashi K, Shimizu Y, Fujimoto R, Yamane R
Intern Med. 2023; 63(2):159-167.
PMID: 37225482
PMC: 10864065.
DOI: 10.2169/internalmedicine.1861-23.
Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction.
Yang Z, Tian R, Zhang X, Cai J, She Z, Li H
Front Cardiovasc Med. 2023; 9:1120085.
PMID: 36712249
PMC: 9877359.
DOI: 10.3389/fcvm.2022.1120085.
Fluorodeoxyglucose-positron emission tomography (FDG-PET) of carotid arteries and non-alcoholic fatty liver disease (NAFLD): An analytical cross-sectional study from a teaching hospital, Kerala, South India.
Rane S, Thachathodiyl R, Palaniswamy S, Menon J, Sudevan R
J Family Med Prim Care. 2022; 11(7):3766-3770.
PMID: 36387669
PMC: 9648243.
DOI: 10.4103/jfmpc.jfmpc_2291_21.
Liver stiffness (Fibroscan®) is a predictor of all-cause mortality in people with non-alcoholic fatty liver disease.
Braude M, Roberts S, Majeed A, Lubel J, Prompen J, Dev A
Liver Int. 2022; 43(1):90-99.
PMID: 36050821
PMC: 10086842.
DOI: 10.1111/liv.15415.
New definition of metabolic dysfunction-associated fatty liver disease with elevated brachial-ankle pulse wave velocity and albuminuria: a prospective cohort study.
Wang J, Liu S, Cao Q, Wu S, Niu J, Zheng R
Front Med. 2022; 16(5):714-722.
PMID: 35507246
DOI: 10.1007/s11684-021-0888-8.
Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis.
Wong M, Yap J, Sultana R, Cheah M, Goh G, Yeo K
Open Heart. 2021; 8(2).
PMID: 34933963
PMC: 8693165.
DOI: 10.1136/openhrt-2021-001850.
Evaluation of subclinical cardiac damage in biopsy-proven nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Oikonomidou A, Doundoulakis I, Antza C, Kalopitas G, Dardavessis T, Chourdakis M
Ann Gastroenterol. 2021; 34(3):424-430.
PMID: 33948069
PMC: 8079885.
DOI: 10.20524/aog.2021.0594.
Cardiac Morphology, Function, and Hemodynamics in Patients With Morbid Obesity and Nonalcoholic Steatohepatitis.
Styczynski G, Kalinowski P, Michalowski L, Paluszkiewicz R, Ziarkiewicz-Wroblewska B, Zieniewicz K
J Am Heart Assoc. 2021; 10(8):e017371.
PMID: 33847141
PMC: 8174163.
DOI: 10.1161/JAHA.120.017371.
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea.
Park J, Lee E, Li J, Jun M, Yoon E, Ahn S
Dig Dis. 2021; 39(6):634-645.
PMID: 33535211
PMC: 8686723.
DOI: 10.1159/000514953.
The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study.
Chiu L, Pedley A, Massaro J, Benjamin E, Mitchell G, McManus D
Liver Int. 2020; 40(10):2445-2454.
PMID: 32654390
PMC: 7669676.
DOI: 10.1111/liv.14600.
Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.
Lee Y, Lai H, de Oliveira Otto M, Lemaitre R, McKnight B, King I
J Am Heart Assoc. 2020; 9(4):e014119.
PMID: 32020839
PMC: 7070205.
DOI: 10.1161/JAHA.119.014119.
Assessment of left ventricular function in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease using three-dimensional speckle-tracking echocardiography.
Dong Y, Cui H, Sun L, Wang Y, Li Y, Chang W
Anatol J Cardiol. 2020; 23(1):41-48.
PMID: 31911565
PMC: 7141431.
DOI: 10.14744/AnatolJCardiol.2019.66805.
Preclinical cardiac disease in nonalcoholic fatty liver disease with and without metabolic syndrome.
Makker J, Tariq H, Bella J, Kumar K, Chime C, Patel H
Am J Cardiovasc Dis. 2019; 9(5):65-77.
PMID: 31763058
PMC: 6872463.
The Association between SOCS1-1656G>A Polymorphism, Insulin Resistance and Obesity in Nonalcoholic Fatty Liver Disease (NAFLD) Patients.
Kempinska-Podhorodecka A, Wunsch E, Milkiewicz P, Stachowska E, Milkiewicz M
J Clin Med. 2019; 8(11).
PMID: 31717271
PMC: 6912432.
DOI: 10.3390/jcm8111912.
Association between nonalcoholic fatty liver disease and cardiac function and structure-a meta-analysis.
Borges-Canha M, Neves J, Libanio D, Von-Hafe M, Vale C, Araujo-Martins M
Endocrine. 2019; 66(3):467-476.
PMID: 31482382
DOI: 10.1007/s12020-019-02070-0.